Dawnrays Pharmaceutical (Holdings) Limited

HKEX:2348.HK

1.12 (HKD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002
Revenue 1,151.1451,277.6821,165.1551,024.27950.007948.938882.483824.351985783.803914.973856.5391,081.0441,286.6831,082.11947.71919.945788.797734.002584.758491.388327.924
Cost of Revenue 509.626511.004489.791478.718427.254353.909320.934312.872415.612323.884511.725532.144718.292910.526754.058691.047680.443604.788518.769392.081285.485155.617
Gross Profit 641.519766.678675.364545.552522.753595.029561.549511.479569.388459.919403.248324.395362.752376.157328.052256.663239.502184.009215.233192.677205.903172.307
Gross Profit Ratio 0.5570.60.580.5330.550.6270.6360.620.5780.5870.4410.3790.3360.2920.3030.2710.260.2330.2930.3290.4190.525
Reseach & Development Expenses 90.80879.47867.02860.03256.08946.35235.64926.72832.5631.38934.56100000000000
General & Administrative Expenses 113.206122.058117.409109.22497.08782.14381.4563.58473.89959.96860.56853.0755.77748.88447.57543.79641.11736.438.59734.37526.09510.643
Selling & Marketing Expenses 147.049142.733109.0354.57284.812106.85488.08698.89594.47199.412112.749104.711100.86195.673101.20679.39569.21853.66954.2358.98756.79552.305
SG&A 260.255264.791226.439163.796181.899190.038170.577163.52169.411160.421174.358157.781156.638144.557148.781123.191110.33590.06992.82793.36282.8962.948
Other Expenses 0.9360.4450.1110.716-68.965-57.398-45.986-38.104-50.121-54.814-51.848-30.5532.69622.17228.02517.41321.9526.5918.21414.85910.5118.767
Operating Expenses 210.136347.751255.626226.886220.876248.803217.463191.575212.724212.389220.025151.996187.903166.729176.806140.604132.285116.659111.041108.22193.40171.715
Operating Income 275.989410.029380.763320.495290.357345.055342.026309.031347.232242.969175.369147.481181.346209.428151.858116.059107.21767.35104.19284.456112.502100.592
Operating Income Ratio 0.240.3210.3270.3130.3060.3640.3880.3750.3530.310.1920.1720.1680.1630.140.1220.1170.0850.1420.1440.2290.307
Total Other Income Expenses Net 138.06828.37958.5610.80323.73732.72223.67724.26829.95715.92413.597-2.84-2.159-0.549-0.395-0.3434.321.9791.7571.956-0.0780.006
Income Before Tax 414.057438.408439.323331.298314.094377.777365.703333.299377.189258.893188.966144.641179.187208.879151.463115.716111.53769.329105.94986.412112.424100.598
Income Before Tax Ratio 0.360.3430.3770.3230.3310.3980.4140.4040.3830.330.2070.1690.1660.1620.140.1220.1210.0880.1440.1480.2290.307
Income Tax Expense 91.3982.55785.1666.50558.73873.81772.72567.38274.99153.74835.86730.13532.8842.04133.11913.58510.383.4510.2456.2253.9960.473
Net Income 326358.057358.175268.13255.43303.96292.978265.917302.198205.145153.099114.506146.307166.84118.388102.037101.15765.878105.70480.171108.022100.119
Net Income Ratio 0.2830.280.3070.2620.2690.320.3320.3230.3070.2620.1670.1340.1350.130.1090.1080.110.0840.1440.1370.220.305
EPS 0.220.240.240.170.160.190.180.170.190.130.0960.0720.0920.110.0760.0650.0630.0410.0660.0480.0780.084
EPS Diluted 0.220.240.240.170.160.190.180.170.190.130.0950.0720.0910.10.0750.0640.0630.0410.0660.0480.0780.084
EBITDA 496.307470.984433.888373.094341.589396.029394361.019400.482288.488209.834177.306209.942235.56177.944140.017131.27290.367121.90697.151118.599105.778
EBITDA Ratio 0.4310.3690.3720.3640.360.4170.4460.4380.4070.3680.2290.2070.1940.1830.1640.1480.1430.1150.1660.1660.2410.323